Hepatitis C virus NS3 serine protease interacts with the serpin Cl inhibitor

被引:12
作者
Drouet, C [1 ]
Bouillet, L [1 ]
Csopaki, F [1 ]
Colomb, MG [1 ]
机构
[1] Univ Grenoble 1, Immunol Lab, Jeune Equipe 1A1, Hop Sud, F-38130 Echirolles, France
关键词
hepatitis C virus; serine protease; non-structural protein 3; serpin;
D O I
10.1016/S0014-5793(99)01194-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both NS3 protein (1007-1657) and its protease moiety (NS3p, 1027-1207) were able to interact in vitro with C1 Inhibitor (C1Inh) to give a 95-kDa M-r C1Inh cleavage product similar to that obtained upon protenlysis by complement protease Cls, High-M-r, reaction products were also detected after incubation of C1Inh with NS3 bat not with NS3p; they correspond to ester-bonded complexes from their hydroxylamine lability, Similar reactivity of NS3 was observed upon incubation with alpha 2-antiplasmin. Serpin cleavage was prevented by treatment of NS3 with synthetic serine protease inhibitors. This interaction between viral NS3 and host serpins suggests that NS3 is likely to be controlled by infected cell protease inhibitors, (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:415 / 418
页数:4
相关论文
共 28 条
[1]   NONSTRUCTURAL PROTEIN-3 OF THE HEPATITIS-C VIRUS ENCODES A SERINE-TYPE PROTEINASE REQUIRED FOR CLEAVAGE AT THE NS3/4 AND NS4/5 JUNCTIONS [J].
BARTENSCHLAGER, R ;
AHLBORNLAAKE, L ;
MOUS, J ;
JACOBSEN, H .
JOURNAL OF VIROLOGY, 1993, 67 (07) :3835-3844
[2]   Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway [J].
Bird, CH ;
Sutton, VR ;
Sun, JR ;
Hirst, CE ;
Novak, A ;
Kumar, S ;
Trapani, JA ;
Bird, PI .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6387-6398
[3]   FLUID-PHASE INTERACTION OF C1BAR INHIBITOR (C1BARINH) AND THE SUB-COMPONENTS C1BARR AND C1BARS OF THE 1ST COMPONENT OF COMPLEMENT, C1BAR [J].
CHESNE, S ;
VILLIERS, CL ;
ARLAUD, GJ ;
LACROIX, MB ;
COLOMB, MG .
BIOCHEMICAL JOURNAL, 1982, 201 (01) :61-70
[4]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[5]   Serine protease inhibitors in patients with chronic viral hepatitis [J].
Elzouki, AN ;
Verbaan, H ;
Lindgren, S ;
Widell, A ;
Carlson, J ;
Eriksson, S .
JOURNAL OF HEPATOLOGY, 1997, 27 (01) :42-48
[6]  
Gils A, 1998, THROMB HAEMOSTASIS, V80, P531
[7]  
Houghton M., 1996, FIELDS VIROLOGY, P1035
[8]   MOLECULAR-CLONING OF THE HUMAN HEPATITIS-C VIRUS GENOME FROM JAPANESE PATIENTS WITH NON-A, NON-B HEPATITIS [J].
KATO, N ;
HIJIKATA, M ;
OOTSUYAMA, Y ;
NAKAGAWA, M ;
OHKOSHI, S ;
SUGIMURA, T ;
SHIMOTOHNO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9524-9528
[9]  
Kerblat I, 1999, IMMUNOLOGY, V97, P62
[10]   In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor [J].
Koch, JO ;
Lohmann, V ;
Herian, U ;
Bartenschlager, R .
VIROLOGY, 1996, 221 (01) :54-66